Search Results - "Elfimova, A R"

Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation by Shestakova, M. V., Vikulova, O. K., Elfimova, A. R., Deviatkin, A. A., Dedov, I. I., Mokrysheva, N. G.

“…The aim To study the association of demographic, clinical, and laboratory factors and the use of glucose-lowering drugs and anti-coronavirus disease (COVID-19)…”
Get full text

Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features by Chevais, A., Elfimova, A. R., Beltsevich, D. G.

“…BACKGROUND : Primary bilateral macronodular adrenal hyperplasia (PBMAH) is characterized by bilateral benign adrenocortical lesions, which in some cases lead…”
Get full text

Comparative analysis of bone complications/manifestations in sporadic and MEN1-related primary hyperparathyroidism by Pylina, S. V., Eremkina, A. K., Elfimova, A. R., Gorbacheva, A. M., Mokrysheva, N. G.

“…BACKGROUND : Multiple endocrine neoplasia type 1 (MEN1) — is a rare syndrome with an autosomal dominant inheritance pattern caused by a mutation in the tumor…”
Get full text

Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism by Elfimova, A. R., Eremkina, A. K., Rebrova, O. Yu, Kovaleva, E. V., Mokrysheva, N. G.

“…BACKGROUND : Primary hyperparathyroidism (PHPT) is a endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH) from parathyroid…”
Get full text

The daily calcium profile in patients with chronic hypoparathyroidism depending on different 25(OH) vitamin D level by Kovaleva, E. V., Eremkina, A. K., Elfimova, A. R., Gorbacheva, A. M., Mokrysheva, N. G.

“…BACKGROUND: Chronic hypoparathyroidism is a relatively rare disease, which usually treated active forms of vitamin D and oral calcium supplements…”
Get full text

Clinical and immunological predictors of Graves’ orbitopathy after radioiodine therapy of Graves’ disease by Sheremeta, M. S., Bessmertnaya, E. G., Elfimova, A. R., Babaeva, D. M., Belovalova, I. M., Sviridenko, N. Yu

“…BACKGROUND: Data on the effect of 131 I on the course of Graves’ orbitopathy (GO) are contradictory. A number of studies indicate a deterioration in the course…”
Get full text

Soluble endoglin as a perspective marker of endothelial dysfunction in patients with primary hyperparathyroidism: a pilot study by Gorbacheva, A. M., Bibik, E. E., Dobreva, E. A., Elfimova, A. R., Eremkina, A. K., Mokrysheva, N. G.

“…BACKGROUND : Primary hyperparathyroidism  (PHPT), one of the most common endocrine pathologies, is associated with a higher incidence of cardiovascular…”
Get full text

Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy by Glibka, A. A., Mazurina, N. V., Troshina, E. A., Sarantseva, K. A., Kharkevich, G. Yu, Volkonskii, M. V., Elfimova, A. R.

“…BACKGROUND: Overweight and obesity have a significant impact on the course and results of treatment of many diseases, including cancer. One of the modern types…”
Get full text

Changes of metabolic parameters in patients with primary hyperparathyroidism of different age groups by Bibik, E. E., Gorbacheva, A. M., Dobreva, E. A., Elfimova, A. R., Eremkina, A. K., Mokrysheva, N. G.

“…BACKGROUND: Studies have shown a high incidence of metabolic disorders and cardiovascular diseases in patients with primary hyperparathyroidism (PHPT). PHPT is…”
Get full text

Reference intervals of thyroidstimulating hormone in pregnant women living in the central regions of the Russian Federation by Rybakova, A. A., Platonov, N. M., Malysheva, N. M., Nikankina, L. V., Elfimova, A. R., Troshina, E. A.

“…BACKGROUND : Pregnancy is a condition with important structural and physiological changes in the thyroid gland. In this regard, experts of thyroid associations…”
Get full text

Predicting the presence of MEN1 gene mutation based on the clinical phenotype of patients with primary hyperparathyroidism by Mokrysheva, N. G., Eremkina, A. K., Miliutina, A. P., Salimkhanov, R. Kh, Aboishava, L. A., Bibik, E. E., Gorbacheva, A. M., Elfimova, A. R., Kovaleva, E. V., Popov, S. V., Melnichenko, G. A.

“…BACKGROUND: Timely referral of patients for genetic testing to rule out MEN1-associated primary PHPT is important factor in determining treatment strategy and…”
Get full text

Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy by Maganeva, I. S., Bondarenko, A. S., Miliutina, A. P., Elfimova, A. R., Bibik, E. E., Nikankina, L. V., Tarbaeva, N. V., Eremkina, A. K., Mokrysheva, N. G.

“…The high prevalence of COVID-19 requires the research progress on the disease pathogenesis. There is a lot of data confirming the association between mineral…”
Get full text

Ethnic differences in risk factors and prevalence of type 2 diabetes in the adult population of the Russian Federation by Kononenko, I. V., Shestakova, M. V., Elfimova, A. R., Khomyakova, I. A., Buzhilova, A. P., Mokrysheva, N. G.

“…BACKGROUND: Russia is one of the most multinational states in the world. Identification of ethnic groups with a higher risk of developing DM2, analysis of risk…”
Get full text

Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian nationwide retrospective study by Mokrysheva, N. G., Shestakova, M. V., Vikulova, O. K., Elfimova, A. R., Isakov, M. A., Gins, N. A., Deviatkin, A. A., Dedov, I. I.

“…BACKGROUND: The coronavirus pandemic has had an extremely negative impact on the patients with diabetes mellitus (DM both in terms of a more severe course of…”
Get full text

The short test with hydrochlorothiazide in differential diagnosis between primary normocalcemic and secondary hyperparathyroidism for inpatient treatment by Eremkina, A. K., Elfimova, A. R., Aboisheva, E. A., Karaseva, E. V., Fadeeva, M. I., Maganeva, I. S., Kovaleva, E. V., Gorbacheva, A. M., Bibik, E. E., Mokrysheva, N. G.

“…BACKGROUND : Differential diagnosis between the normocalcemic primary hyperparathyroidism (nPHPT) and secondary hyperparathyroidism (SHPT) due to…”
Get full text

Universal histological system for assessing the malignancy potential of tumors of the adrenal cortex in adults by Pachuashvili, N. V., Porubaeva, E. E., Elfimova, A. R., Urusova, L. S.

Get full text

Prediction of the development of hypocalcemia in primary hyperparathyroidism patients 1–3 days after radical parathyroidectomy by Elfimova, A. R., Eremkina, A. K., Rebrova, O. Yu, Kovaleva, E. V., Mokrysheva, N. G.

“…B ACKGROUND: It was impossible to predict the development of hypocalcemia following parathyroidectomy (PTE) in patients with primary hyperparathyroidism (PHPT)…”
Get full text

Insulinoma: analysis of prevalence and incidence in the world by Yukina, M. Yu, Elfimova, A. R., Troshina, E. A., Melnichenko, G. A., Mokrysheva, N. G.

“…BACKGROUND : Currently, there are no data on the prevalence and incidence of insulinoma in Russia. The published world data on the epidemiology of the tumor…”
Get full text

Unilateral adrenalectomy for primary bilateral macronodular adrenal hyperplasia by Chevais, A., Elfimova, A. R., Derkatch, D. A., Romanova, A. N., Ebzeeva, A.  K.

“…BACKGROUND: To date, surgical treatment is an effective treatment of hypercortisolism in primary bilateral macronodular hyperplasia (PBMAH). Due to the…”
Get full text

Complications of chronic hypoparathyroidism according to analysis database Russian Registry by Kovaleva, E. V., Salimkhanov, R. K., Elfimova, A. R., Eremkina, A. K., Pershina-Miliutina, A. P., Bibik, E. E., Gorbacheva, A. M., Vikulova, O. K., Mokrysheva, N. G.

“…BACKGROUND . Chronic hypoparathyroidism (HypoPT) is a relatively rare endocrine disorder. Adequate control of the disease requires the prescription of lifelong…”
Get full text